Where others see complexity, we see potential for growth.
We develop, manufacture, market and distribute specialty treatments.
Mallinckrodt is a global specialty pharmaceutical business that develops, manufactures, markets and distributes specialty pharmaceutical products.
Areas of focus include therapeutic drugs for autoimmune and rare disease specialty areas like neurology, rheumatology, nephrology and pulmonology; neonatal critical care respiratory therapies; and analgesics and hemostasis products.
The company’s Specialty Brands segment includes branded medicines/devices; and its Specialty Generics segment includes specialty generic drugs and active pharmaceutical ingredients.
Users agree that access to and use of any website linked from this site and the content of either is at their own risk. Mallinckrodt Canada shall not be liable in any matter whatsoever for any direct, incidental, consequential, indirect or punitive damages arising from the access to, use of, or inability to use this website or any website linked to this site or for any errors or omissions in the content of either this website or any website linked to this site.